All Relations between dopamine and cannabis

Publication Sentence Publish Date Extraction Date Species
Rassil Ghazzaoui, Anissa Abi-Dargha. Imaging dopamine transmission parameters in cannabis dependence. Progress in neuro-psychopharmacology & biological psychiatry. vol 52. 2014-12-12. PMID:24513022. imaging dopamine transmission parameters in cannabis dependence. 2014-12-12 2023-08-12 Not clear
Bertha K Madra. Dopamine challenge reveals neuroadaptive changes in marijuana abusers. Proceedings of the National Academy of Sciences of the United States of America. vol 111. issue 33. 2014-11-03. PMID:25114244. dopamine challenge reveals neuroadaptive changes in marijuana abusers. 2014-11-03 2023-08-13 Not clear
Nora D Volkow, Gene-Jack Wang, Frank Telang, Joanna S Fowler, David Alexoff, Jean Logan, Millard Jayne, Christopher Wong, Dardo Tomas. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proceedings of the National Academy of Sciences of the United States of America. vol 111. issue 30. 2014-10-31. PMID:25024177. decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. 2014-10-31 2023-08-13 human
Nora D Volkow, Gene-Jack Wang, Frank Telang, Joanna S Fowler, David Alexoff, Jean Logan, Millard Jayne, Christopher Wong, Dardo Tomas. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proceedings of the National Academy of Sciences of the United States of America. vol 111. issue 30. 2014-10-31. PMID:25024177. here, we challenged 48 participants (24 controls and 24 marijuana abusers) with methylphenidate (mp), a drug that elevates extracellular dopamine (da) as a surrogate for probing the reactivity of the brain to da stimulation. 2014-10-31 2023-08-13 human
Robin M Murray, Alessandra Paparelli, Paul D Morrison, Arianna Marconi, Marta Di Fort. What can we learn about schizophrenia from studying the human model, drug-induced psychosis? American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 162B. issue 7. 2014-05-27. PMID:24132898. research into the effects of lsd initiated the serotonergic model; amphetamines the dopamine hypothesis, pcp and ketamine the glutamatergic hypothesis, while most recently the effects of cannabis have provoked interest in the role of endocannabinoids in schizophrenia. 2014-05-27 2023-08-12 human
Rebecca Kuepper, Jenny Ceccarini, Johan Lataster, Jim van Os, Marinus van Kroonenburgh, Joop M A van Gerven, Machteld Marcelis, Koen Van Laere, Cécile Henque. Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study. PloS one. vol 8. issue 7. 2014-03-05. PMID:23936196. we used positron emission tomography and (18)f-fallypride to test the hypothesis that genetic risk for psychosis is expressed by differential induction of dopamine release by Δ(9)-thc (delta-9-tetrahydrocannabinol, the main psychoactive ingredient of cannabis). 2014-03-05 2023-08-12 Not clear
Rebecca Kuepper, Jenny Ceccarini, Johan Lataster, Jim van Os, Marinus van Kroonenburgh, Joop M A van Gerven, Machteld Marcelis, Koen Van Laere, Cécile Henque. Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study. PloS one. vol 8. issue 7. 2014-03-05. PMID:23936196. in a single dynamic pet scanning session, striatal dopamine release after pulmonary administration of Δ(9)-thc was measured in 9 healthy cannabis users (average risk psychotic disorder), 8 patients with psychotic disorder (high risk psychotic disorder) and 7 un-related first-degree relatives (intermediate risk psychotic disorder). 2014-03-05 2023-08-12 Not clear
Romina Mizrahi, Ivonne Suridjan, Miran Kenk, Tony P George, Alan Wilson, Sylvain Houle, Pablo Rusja. Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 38. issue 4. 2013-10-29. PMID:23212454. dopamine response to psychosocial stress in chronic cannabis users: a pet study with [11c]-+-phno. 2013-10-29 2023-08-12 human
Erik B Oleson, Joseph F Chee. A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harbor perspectives in medicine. vol 2. issue 8. 2013-06-26. PMID:22908200. increases in mesolimbic dopamine transmission are observed when animals are treated with all known drugs of abuse, including cannabis, and to conditioned stimuli predicting their availability. 2013-06-26 2023-08-12 Not clear
Roy Otten, Edward D Barker, Anja C Huizink, Rutger C M E Engel. The interplay between parental monitoring and the dopamine D4 receptor gene in adolescent cannabis use. PloS one. vol 7. issue 11. 2013-06-11. PMID:23209577. the interplay between parental monitoring and the dopamine d4 receptor gene in adolescent cannabis use. 2013-06-11 2023-08-12 Not clear
Claire Leroy, Laurent Karila, Jean-Luc Martinot, Michaël Lukasiewicz, Edouard Duchesnay, Claude Comtat, Frédéric Dollé, Amine Benyamina, Eric Artiges, Maria-Joao Ribeiro, Michel Reynaud, Christian Trichar. Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study. Addiction biology. vol 17. issue 6. 2013-04-15. PMID:21812871. striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution pet study. 2013-04-15 2023-08-12 human
Claire Leroy, Laurent Karila, Jean-Luc Martinot, Michaël Lukasiewicz, Edouard Duchesnay, Claude Comtat, Frédéric Dollé, Amine Benyamina, Eric Artiges, Maria-Joao Ribeiro, Michel Reynaud, Christian Trichar. Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study. Addiction biology. vol 17. issue 6. 2013-04-15. PMID:21812871. in order to assess striatal and extrastriatal dopamine transporter (dat) availability in tobacco and cannabis addiction, three groups of male age-matched subjects were compared: 11 healthy non-smoker subjects, 14 tobacco-dependent smokers (17.6 ± 5.3 cigarettes/day for 12.1 ± 8.5 years) and 13 cannabis and tobacco smokers (cts) (4.8 ± 5.3 cannabis joints/day for 8.7 ± 3.9 years). 2013-04-15 2023-08-12 human
Jose Maria Pelayo-Terán, Paula Suárez-Pinilla, Nicholas Chadi, Benedicto Crespo-Facorr. Gene-environment interactions underlying the effect of cannabis in first episode psychosis. Current pharmaceutical design. vol 18. issue 32. 2013-03-25. PMID:22716151. cannabis use has been shown to act together with other environmental factors such as childhood trauma or urbanicity producing synergistic dopamine sensitization effects. 2013-03-25 2023-08-12 Not clear
Aine T Behan, Magdalena Hryniewiecka, Colm M P O'Tuathaigh, Anthony Kinsella, Mary Cannon, Maria Karayiorgou, Joseph A Gogos, John L Waddington, David R Cotte. Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 37. issue 7. 2012-09-21. PMID:22434221. a high-low activity polymorphism in catechol-o-methyltransferase (comt), a gene encoding the comt enzyme involved in dopamine clearance in the brain, may interact with adolescent cannabis exposure to increase risk for schizophrenia. 2012-09-21 2023-08-12 mouse
Nina B L Urban, Diana Martine. Neurobiology of addiction: insight from neurochemical imaging. The Psychiatric clinics of North America. vol 35. issue 2. 2012-09-06. PMID:22640769. predominantly reduced striatal dopamine transmission appears to play an important role in psychostimulant, alcohol and heroin addiction, while addiction to cannabis may be mediated primarily by the endocannabinoid system. 2012-09-06 2023-08-12 human
Paul R A Stokes, Alice Egerton, Ben Watson, Alistair Reid, Julia Lappin, Oliver D Howes, David J Nutt, Anne R Lingford-Hughe. History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. Journal of psychopharmacology (Oxford, England). vol 26. issue 1. 2012-08-21. PMID:21890594. history of cannabis use is not associated with alterations in striatal dopamine d2/d3 receptor availability. 2012-08-21 2023-08-12 human
Paul R A Stokes, Alice Egerton, Ben Watson, Alistair Reid, Julia Lappin, Oliver D Howes, David J Nutt, Anne R Lingford-Hughe. History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. Journal of psychopharmacology (Oxford, England). vol 26. issue 1. 2012-08-21. PMID:21890594. we sought to examine whether striatal dopamine d(2)/d(3) receptor availability was altered in volunteers with a history of cannabis use using a database of previously acquired [(11)c]-raclopride positron emission tomography (pet) scans. 2012-08-21 2023-08-12 human
Paul R A Stokes, Alice Egerton, Ben Watson, Alistair Reid, Julia Lappin, Oliver D Howes, David J Nutt, Anne R Lingford-Hughe. History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. Journal of psychopharmacology (Oxford, England). vol 26. issue 1. 2012-08-21. PMID:21890594. these findings suggest that, unlike other drugs of abuse, a history of cannabis use is not associated with alterations in striatal dopamine d(2)/d(3) receptor availability. 2012-08-21 2023-08-12 human
Nina B L Urban, Mark Slifstein, Judy L Thompson, Xiaoyan Xu, Ragy R Girgis, Sonia Raheja, Margaret Haney, Anissa Abi-Dargha. Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Biological psychiatry. vol 71. issue 8. 2012-08-16. PMID:22290115. dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. 2012-08-16 2023-08-12 human
Jennifer A DiNieri, Xinyu Wang, Henrietta Szutorisz, Sabrina M Spano, Jasbir Kaur, Patrizia Casaccia, Diana Dow-Edwards, Yasmin L Hur. Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biological psychiatry. vol 70. issue 8. 2012-01-31. PMID:21820648. maternal cannabis use alters ventral striatal dopamine d2 gene regulation in the offspring. 2012-01-31 2023-08-12 Not clear